Literature DB >> 10026384

Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study.

Z Nagy1, N J Hindley, H Braak, E Braak, D M Yilmazer-Hanke, C Schultz, L Barnetson, K A Jobst, A D Smith.   

Abstract

The distribution of pathology related to Alzheimer's disease (AD) is not uniform throughout the brain. Sites which have a predilection for the development of Alzheimer-type pathology are the limbic regions and neocortical association areas. The changes in these areas of the brain develop gradually, following a well-determined sequence that allows a pathological staging of the disease process. According to the staging hypothesis, the first pathological alterations develop in the transentorhinal and entorhinal regions. The neurofibrillary pathology then spreads into the hippocampus, but not until the final stages does it affect the neocortex. In this study we analyse the relationship between the pathological stages of AD, according ot the staging hypothesis, and the clinical diagnosis in a prospectively assessed patient group. Prediction of any given pathological stage from the clinical diagnosis was found to be poor. This may be partly due to the fact that additional pathologies can alter the clinical picture and severity of dementia in patients who are only in the initial stages of AD. Nevertheless, the NINCDS-ADRDA clinical criteria had a high sensitivity for detection of AD-related pathology: the 'probable AD' category included 22/38 (57.9%) of those in the late isocortical stage, while the 'possible AD' category included 19/23 (82.6%) of those in the limbic stage. Using proposed neuro-imaging protocols for improved identification of patients with AD-related pathology, we largely identified subjects in whom the extent of pathology had spread to the neocortex.

Entities:  

Mesh:

Year:  1999        PMID: 10026384     DOI: 10.1159/000017110

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

1.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors:  C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

Review 2.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

3.  Use of fuzzy edge single-photon emission computed tomography analysis in definite Alzheimer's disease--a retrospective study.

Authors:  Robert Rusina; Jaromír Kukal; Tomás Belícek; Marie Buncová; Radoslav Matej
Journal:  BMC Med Imaging       Date:  2010-09-01       Impact factor: 1.930

4.  Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage.

Authors:  Prashanthi Vemuri; Jennifer L Whitwell; Kejal Kantarci; Keith A Josephs; Joseph E Parisi; Maria S Shiung; David S Knopman; Bradley F Boeve; Ronald C Petersen; Dennis W Dickson; Clifford R Jack
Journal:  Neuroimage       Date:  2008-05-20       Impact factor: 6.556

5.  Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.

Authors:  Gustavo Basurto-Islas; Jose Luna-Muñoz; Angela L Guillozet-Bongaarts; Lester I Binder; Raul Mena; Francisco García-Sierra
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

6.  Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD.

Authors:  Stephanie A Schultz; Jennifer M Oh; Rebecca L Koscik; N Maritza Dowling; Catherine L Gallagher; Cynthia M Carlsson; Barbara B Bendlin; Asenath LaRue; Bruce P Hermann; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson; Ozioma C Okonkwo
Journal:  Alzheimers Dement (Amst)       Date:  2015-03-01

7.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.